Revista de Odontologia da UNESP
http://revodontolunesp.com.br/article/doi/10.1590/1807-2577.19415
Revista de Odontologia da UNESP
Original Article

Efeitos do metilfenidato sobre as glândulas salivares maternas de camundongos

Methylphenidate effects on maternal salivary glands of mice

Lima, Karol Sartori; Salles, Antonio Eduardo; Costa, Gabriel Araujo; Ramos, Solange Paula; Salles, Maria José Sparça

Downloads: 3
Views: 386

Resumo

Introdução: O metilfenidato (MFD) é um derivado anfetamínico estimulante do sistema nervoso central, que vem sendo cada vez mais consumido pela população mundial, incluindo as mulheres em idade fértil. Ainda não foram estabelecidos os efeitos deste medicamento nas glândulas salivares, durante a gestação. Objetivo: Identificar alterações histomorfológicas em glândulas salivares maternas expostas ao metilfenidato. Material e método: Para análise histológica, foram utilizadas 32 fêmeas de camundongos Swiss prenhes, distribuídas em um grupo controle e um grupo tratado. A administração foi realizada do quinto ao 17o dia de gestação, via injeção subcutânea; o grupo tratado recebeu 5 mg/kg de metilfenidato, enquanto o grupo controle recebeu o mesmo volume de solução salina estéril. As fêmeas foram eutanasiadas e tiveram suas glândulas salivares removidas e incluídas em parafina para análise em microscopia óptica. Para avaliar a associação entre as variáveis dos grupos, o teste de Kolmogorov-Smirnov e o teste T foram utilizados. Resultado: As glândulas parótidas do grupo tratado apresentaram alterações no raio dos ductos e na quantidade de ácinos, quando comparadas às glândulas parótidas do grupo controle. A glândula submandibular do grupo tratado foi a mais afetada: mostrou diferença estatisticamente significativa na espessura da parede dos ductos secretores, no raio dos ductos e no raio dos ácinos, quando comparada à glândula submandibular do grupo controle. A glândula sublingual não apresentou alterações significativas. Conclusão: Neste delineamento experimental, o metilfenidato apresentou-se como agente indutor de alterações morfológicas das glândulas salivares, promovendo alterações significativas nos raios de ductos e ácinos das mesmas, sendo a glândula submandibular a mais susceptível a este fármaco.

Palavras-chave

Metilfenidato, glândulas salivares, gestação.

Abstract

Introduction: Methylphenidate (MFD) is a stimulant amphetamine derivative of the central nervous system, which is being increasingly consumed by the world population, including women of childbearing age. It has not yet established the effects of this medicine in the salivary glands during pregnancy. Objective: Evaluate the exposure effects to the MPD in the maternal salivary glands. Material and method: For prenatal study, 32 pregnant female Swiss mice were used, divided into a control and a treated group. The treated group received 5 mg/kg of MPD via subcutaneous injection from the 5th to the 17th day and the control received sterile saline in the same volume and pregnancy period. Females were euthanized and had their salivary glands removed and embedded in paraffin for analysis in optical microscopy. To evaluate the association between the variables of the groups, the Kolmogorov-Smirnov test and and T test were used. Result: The parotid glands of the treated group showed statistically significant change within the ducts and the amount of acini when compared to the control group. The submandibular gland was the most affected, it showed a difference statistically significant in wall thickness of the secretory ducts, within the ducts and within the acini when compared to the control group. The sublingual gland showed no significant changes. Conclusion: In this experiment methylphenidate is presented as inducing agent morphological changes of the salivary glands, promoting significant changes in ducts radii and acini, submandibular gland being more susceptible to this drug.

Keywords

Methylphenidate, salivary glands, pregnancy.

References

1. Biederman J, Faraone SV. Attention-deficit hyperactivity disorder. Lancet. 2005 Jul;366(9481):237-48. PMid:16023516. http://dx.doi.org/10.1016/S0140-6736(05)66915-2.

2. Freese L, Signor L, Machado C, Ferigolo M, Barros HMT. Non-medical use of methylphenidate: a review. Trends Psychiatry Psychother. 2012;34(2):110-5. PMid:25922930. http://dx.doi.org/10.1590/S2237-60892012000200010.

3. International Narcotics Control Board. Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances. Report of the International Narcotics Control Board for 2012 on the Implementation of Article 12 of the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (E/INCB/2012/4); 2012 fev 28; New Delhi. New York: United Nations Publication; 2013. p. 36-47.

4. Arria AM, Wish ED. Nonmedical use of prescription stimulants among students. Pediatr Ann. 2006 Aug;35(8):565-71. PMid:16986451. http://dx.doi.org/10.3928/0090-4481-20060801-09.

5. Panos JJ, Law CD, Ferguson SA. Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague-Dawley offspring. Neurotoxicol Teratol. 2014 Mar-Apr;42:9-16. PMid:24444667. http://dx.doi.org/10.1016/j.ntt.2014.01.004.

6. McFadyen-Leussis MP, Lewis SP, Bond TL, Carrey N, Brown RE. Prenatal exposure to methylphenidate hydrochloride decreases anxiety and increases exploration in mice. Pharmacol Biochem Behav. 2004 Mar;77(3):491-500. PMid:15006459. http://dx.doi.org/10.1016/j.pbb.2003.12.011.

7. Nanci A. Ten Cate histologia oral: desenvolvimento, estrutura e função. 8. ed. Rio de Janeiro: Elsevier; 2013.

8. Laine M, Pienihäkkinen K. Salivary buffer effect in relation to late pregnancy and postpartum. Acta Odontol Scand. 2000;58(1):8-10. PMid:10809393. http://dx.doi.org/10.1080/000163500429361.

9. Laine M, Tenovuo J, Lehtonen OP, Ojanotko-Harri A, Vilja P, Tuohimaa P. Pregnancy-related changes in human whole saliva. Arch Oral Biol. 1988;33(12):913-7. PMid:3256298. http://dx.doi.org/10.1016/0003-9969(88)90022-2.

10. Gonzalez M, Monte de Oca L, Jimenez G. Cambios en la composición de la saliva de pacientes gestantes y no gestantes. Perinatol Reprod Hum. 2001 Jul-Set;15(3):195-201.

11. Kivelä J, Laine M, Parkkila S, Rajaniemi H. Salivary carbonic anhydrase VI and its relation to salivary flow rate and buffer capacity in pregnant and non-pregnant women. Arch Oral Biol. 2003 Aug;48(8):547-51. PMid:12828982. http://dx.doi.org/10.1016/S0003-9969(03)00096-7.

12. Mattioli TMF, Silva S, Grégio AMT, Machado MAN, Lima AAS, Azevedo-Alanis LR. The effects of antidepressants and pilocarpine on rat parotid glands: an immunohistochemical study. Clinics (Sao Paulo). 2011 Sep;66(9):1605-10. PMid:22179167. http://dx.doi.org/10.1590/S1807-59322011000900017.

13. Wu A, Ship JA. A characterization of major salivary gland flow rates in the presence of medications and systemic diseases. Oral Surg Oral Med Oral Pathol. 1993 Sep;76(3):301-6. PMid:8378045. http://dx.doi.org/10.1016/0030-4220(93)90258-6.

14. Eisenberg MJ, Filion KB, Yavin D, Bélisle P, Mottillo S, Joseph L, et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ. 2008 Jul;179(2):135-44. PMid:18625984. http://dx.doi.org/10.1503/cmaj.070256.

15. Thomson WM, Chalmers JM, Spencer AJ, Slade GD. Medication and dry mouth: findings from a cohort study of older people. J Public Health Dent. 2000;60(1):12-20. PMid:10734611. http://dx.doi.org/10.1111/j.1752-7325.2000.tb03286.x.

16. Aranha FL. Bioquímica odontológica. São Paulo: Sarvier; 1996.

17. Vissink A, Waterman HA, ‘s-Gravenmade EJ, Panders AK, Vermey A. Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose or poliethylenoxide. J Oral Pathol. 1984 Feb;13(1):22-8. PMid:6422019. http://dx.doi.org/10.1111/j.1600-0714.1984. tb01397.x.

18. Rang HP, Dale MM, Ritter JM, Flower RJ. Farmacologia. 6. ed. Rio de Janeiro: Elsevier; 2007.

19. Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60(Suppl 4):4-11, discussion 12-3. PMid:10086478.

20. Horst WD, Preskorn SH. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. J Affect Disord. 1998 Dec;51(3):237-54. PMid:10333980. http://dx.doi.org/10.1016/S0165-0327(98)00222-5.

21. Bezchlibnyk-Butler KZ, Jeffries JJ. Clinical handbook of psychotropic drugs. 9th ed. Seattle: Hogrefe & Huber; 1999.

588019ed7f8c9d0a098b53d2 rou Articles
Links & Downloads

Rev. odontol. UNESP

Share this page
Page Sections